文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

用于评估黏膜下结直肠癌淋巴结转移的复合评分系统和最佳肿瘤芽计数切点。

Composite scoring system and optimal tumor budding cut-off number for estimating lymph node metastasis in submucosal colorectal cancer.

机构信息

Department of Surgery, Chung-Ang University Hospital, 06973, Seoul, Republic of Korea.

Chung-Ang University College of Medicine, 06973, Seoul, Republic of Korea.

出版信息

BMC Cancer. 2022 Aug 6;22(1):861. doi: 10.1186/s12885-022-09957-8.


DOI:10.1186/s12885-022-09957-8
PMID:35933369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9357306/
Abstract

BACKGROUND: Tumor budding is associated with lymph node (LN) metastasis in submucosal colorectal cancer (CRC). However, the rate of LN metastasis associated with the number of tumor buds is unknown. Here, we determined the optimal tumor budding cut-off number and developed a composite scoring system (CSS) for estimating LN metastasis of submucosal CRC. METHODS: In total, 395 patients with histologically confirmed T1N0-2M0 CRC were evaluated. The clinicopathological characteristics were subjected to univariate and multivariate analyses. The Akaike information criterion (AIC) values of the multivariate models were evaluated to identify the optimal cut-off number. A CSS for LN metastasis was developed using independent risk factors. RESULTS: The prevalence of LN metastasis was 13.2%. Histological differentiation, lymphatic or venous invasion, and tumor budding were associated with LN metastasis in univariate analyses. In multivariate models adjusted for histological differentiation and lymphatic or venous invasion, the AIC value was lowest for five tumor buds. Unfavorable differentiation (odds ratio [OR], 8.16; 95% confidence interval [CI], 1.80-36.89), lymphatic or venous invasion (OR, 5.91; 95% CI, 2.91-11.97), and five or more tumor buds (OR, 3.01; 95% CI, 1.21-7.69) were independent risk factors. In a CSS using these three risk factors, the rates of LN metastasis were 5.6%, 15.5%, 31.0%, and 52.4% for total composite scores of 0, 1, 2, and ≥ 3, respectively. CONCLUSIONS: For the estimation of LN metastasis in submucosal CRC, the optimal tumor budding cut-off number was five. Our CSS can be utilized to estimate LN metastasis.

摘要

背景:肿瘤芽与黏膜下结直肠癌(CRC)的淋巴结(LN)转移相关。然而,与肿瘤芽数量相关的 LN 转移率尚不清楚。本研究旨在确定最佳的肿瘤芽截断数量,并建立一个用于估计黏膜下 CRC 淋巴结转移的复合评分系统(CSS)。

方法:共评估了 395 例经组织学证实的 T1N0-2M0 CRC 患者。对临床病理特征进行单因素和多因素分析。通过评估多变量模型的赤池信息量准则(AIC)值来确定最佳截断数量。使用独立的危险因素建立用于 LN 转移的 CSS。

结果:LN 转移的发生率为 13.2%。组织学分化、淋巴管或静脉侵犯以及肿瘤芽与 LN 转移在单因素分析中相关。在多变量模型中,对组织学分化和淋巴管或静脉侵犯进行调整后,肿瘤芽数量为 5 个时 AIC 值最低。分化不良(优势比 [OR],8.16;95%置信区间 [CI],1.80-36.89)、淋巴管或静脉侵犯(OR,5.91;95% CI,2.91-11.97)和 5 个或更多肿瘤芽(OR,3.01;95% CI,1.21-7.69)是独立的危险因素。在使用这三个危险因素的 CSS 中,总复合评分分别为 0、1、2 和≥3 时,LN 转移率分别为 5.6%、15.5%、31.0%和 52.4%。

结论:对于黏膜下 CRC 的 LN 转移评估,最佳的肿瘤芽截断数量为 5 个。我们的 CSS 可用于估计 LN 转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6e1/9357306/8e272a2e9c21/12885_2022_9957_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6e1/9357306/720610f89a3f/12885_2022_9957_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6e1/9357306/c59f2a28c7df/12885_2022_9957_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6e1/9357306/2d7c6bca06b4/12885_2022_9957_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6e1/9357306/beb73abd75f8/12885_2022_9957_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6e1/9357306/8e272a2e9c21/12885_2022_9957_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6e1/9357306/720610f89a3f/12885_2022_9957_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6e1/9357306/c59f2a28c7df/12885_2022_9957_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6e1/9357306/2d7c6bca06b4/12885_2022_9957_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6e1/9357306/beb73abd75f8/12885_2022_9957_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6e1/9357306/8e272a2e9c21/12885_2022_9957_Fig5_HTML.jpg

相似文献

[1]
Composite scoring system and optimal tumor budding cut-off number for estimating lymph node metastasis in submucosal colorectal cancer.

BMC Cancer. 2022-8-6

[2]
Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer.

Colorectal Dis. 2013-7

[3]
The significance of tumor budding in T1 colorectal carcinoma: the most reliable predictor of lymph node metastasis especially in endoscopically resected T1 colorectal carcinoma.

Hum Pathol. 2018-2-13

[4]
A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study.

Mod Pathol. 2015-6

[5]
Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma.

Mod Pathol. 2010-5-14

[6]
Prognostic and diagnostic significance of tumor budding associated with β-catenin expression in submucosal invasive colorectal carcinoma.

Tohoku J Exp Med. 2013-1

[7]
The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study.

BMC Med. 2017-7-14

[8]
Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.

Scand J Gastroenterol. 2009

[9]
Immunohistochemical evaluation of tumor budding for stratifying T1 colorectal cancer: optimal cut-off value and a novel computer-assisted semiautomatic method.

Mod Pathol. 2018-12-14

[10]
Risk Factors for Lymph Node Metastasis and Recurrence in T1 Colorectal Cancer: Analysis of 801 Patients in a Single Institute.

Am Surg. 2023-12

引用本文的文献

[1]
Tumor Budding as a Risk Factor for Lymph Node Metastasis and Local Recurrence in pT1 Colorectal Cancer: A Systematic Review and Meta-Analysis.

Gastro Hep Adv. 2025-5-27

[2]
The oncogenic role of hypomethylated ZNF793 in gastric carcinoma: a focus on cell survival and stemness.

Gastric Cancer. 2025-6-22

[3]
Investigation of three alternative histopathological scoring methods at the invasive tumour front in colorectal cancer.

J Pathol Clin Res. 2025-5

[4]
Comparison of the prognosis and lymph node metastasis between no tumor budding and low-grade tumor budding in T1 and T2 colorectal cancer.

Sci Rep. 2025-1-2

[5]
Variation in the detection of lymphovascular invasion in T1 colorectal cancer and its impact on treatment: A nationwide Dutch study.

United European Gastroenterol J. 2024-12

[6]
Deep learning application in prediction of cancer molecular alterations based on pathological images: a bibliographic analysis via CiteSpace.

J Cancer Res Clin Oncol. 2024-10-18

[7]
Refining Risk Criteria May Substantially Reduce Unnecessary Additional Surgeries after Local Resection of T1 Colorectal Cancer.

Cancers (Basel). 2024-6-25

[8]
Adapting SAM to Histopathology Images for Tumor Bud Segmentation in Colorectal Cancer.

Proc SPIE Int Soc Opt Eng. 2024-2

[9]
Few-shot Tumor Bud Segmentation Using Generative Model in Colorectal Carcinoma.

Proc SPIE Int Soc Opt Eng. 2024-2

[10]
Effects of tumour budding on adjuvant chemotherapy in colorectal cancer.

BJS Open. 2024-1-3

本文引用的文献

[1]
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

J Natl Compr Canc Netw. 2021-3-2

[2]
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2020-10

[3]
Risk factors and predictors of lymph nodes metastasis and distant metastasis in newly diagnosed T1 colorectal cancer.

Cancer Med. 2020-7

[4]
Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer.

Clin Endosc. 2020-3

[5]
Lymphovascular Infiltration, Not Depth of Invasion, is the Critical Risk Factor of Metastases in Early Colorectal Cancer: Retrospective Population-based Cohort Study on Prospectively Collected Data, Including Validation.

Ann Surg. 2022-1-1

[6]
Standardized Pathology Report for Colorectal Cancer, 2nd Edition.

J Pathol Transl Med. 2020-1

[7]
Additional surgery after endoscopic submucosal dissection for colorectal cancer: a review of 53 cases.

Int J Colorectal Dis. 2019-9-2

[8]
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.

Int J Clin Oncol. 2019-6-15

[9]
Nomogram Development and External Validation for Predicting the Risk of Lymph Node Metastasis in T1 Colorectal Cancer.

Cancer Res Treat. 2019-1-17

[10]
Histologic Factors Associated With Need for Surgery in Patients With Pedunculated T1 Colorectal Carcinomas.

Gastroenterology. 2018-1-31

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索